BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23259831)

  • 41. Management of locally advanced cervical cancer.
    Rojas-Espaillat LA; Rose PG
    Curr Opin Oncol; 2005 Sep; 17(5):485-92. PubMed ID: 16093801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma].
    Nöel G; Mazeron JJ
    Cancer Radiother; 1999; 3(4):345-7. PubMed ID: 10515699
    [No Abstract]   [Full Text] [Related]  

  • 43. [Progress in the treatment of cervical cancer].
    Sugimori H
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1840-6. PubMed ID: 3382236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer.
    Mizunuma M; Yokoyama Y; Futagami M; Aoki M; Takai Y; Mizunuma H
    Int J Clin Oncol; 2015 Oct; 20(5):989-96. PubMed ID: 25736530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma.
    Tang J; Tang Y; Yang J; Huang S
    Gynecol Oncol; 2012 May; 125(2):297-302. PubMed ID: 22307061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
    Chen CC; Lin JC; Jan JS; Ho SC; Wang L
    Gynecol Oncol; 2011 Jul; 122(1):9-13. PubMed ID: 21514629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival benefits of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy in locally advanced chemoresistant cervical cancer.
    Choi YS; Sin JI; Kim JH; Ye GW; Shin IH; Lee TS
    J Korean Med Sci; 2006 Aug; 21(4):683-9. PubMed ID: 16891813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multimodal treatment of locally advanced cervical cancer.
    Dueñas-González A; Cetina-Pérez L; Oñate-Ocaña LF; Rivera L; Lopez-Graniel C; González-Enciso A; Candelaria M; Mohar A
    Arch Med Res; 2005; 36(2):129-35. PubMed ID: 15847945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Counterpoint: test the value of hyperthermia in patients with carcinoma of the cervix being treated with concurrent chemotherapy and radiation.
    Prosnitz L; Jones E
    Int J Hyperthermia; 2002; 18(1):13-8. PubMed ID: 11820463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined-modality therapy of locally advanced cervical cancer.
    Rose PG
    J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemoradiation for carcinoma of the cervix: advances and opportunities.
    Eifel PJ
    Radiat Res; 2000 Sep; 154(3):229-36. PubMed ID: 11012341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New approaches for the management of cervical cancer.
    Herzog TJ
    Gynecol Oncol; 2003 Sep; 90(3 Pt 2):S22-7. PubMed ID: 13129492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
    van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
    Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent weekly cis-platinum and radiotherapy in advanced cervical cancer: a preliminary dose escalating toxicity study.
    Twiggs LB; Potish RA; McIntyre S; Adcock LL; Savage JE; Prem KA
    Gynecol Oncol; 1986 Jun; 24(2):143-8. PubMed ID: 3086189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent developments in chemoradiotherapy for locally advanced cancer of the cervix.
    Kim RY; Alvarez RD
    Oncology (Williston Park); 2000 Sep; 14(9):1327-31, 1335; discussion 1336-8. PubMed ID: 11033830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long-term results of comprehensive treatment for cervical cancer with poor prognosis].
    Vishnevskaia EE; Kosenko IA
    Vopr Onkol; 1999; 45(4):420-3. PubMed ID: 10532103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.
    Tambaro R; Scambia G; Di Maio M; Pisano C; Barletta E; Iaffaioli VR; Pignata S
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):33-44. PubMed ID: 15363465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective quality of life study of South African women undergoing treatment for advanced-stage cervical cancer.
    du Toit GC; Kidd M
    Clin Ther; 2015 Oct; 37(10):2324-31. PubMed ID: 26385584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of metastatic cervical cancer: future directions involving targeted agents.
    Diaz-Padilla I; Monk BJ; Mackay HJ; Oaknin A
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):303-14. PubMed ID: 22883215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global strategies for the treatment of early-stage and advanced cervical cancer.
    Dueñas-González A; Campbell S
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):11-7. PubMed ID: 26626039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.